<?xml version="1.0" encoding="UTF-8"?>
<p>The increasing resistance to bnAbs observed on T/F viruses sampled from infected individuals over the course of the epidemic raises the issue of the panels used to evaluate bnAbs and vaccine-induced anti-HIV-1 humoral response [
 <xref rid="B63-vaccines-07-00074" ref-type="bibr">63</xref>,
 <xref rid="B94-vaccines-07-00074" ref-type="bibr">94</xref>] and the necessity of updating them in the future. In other words, it is important to keep monitoring the sensitivity of HIV-1 to bnAbs over the course of the epidemic to better characterize its evolution for different clades and how it could impact immunization strategies.
</p>
